Aptamer therapeutics useful in ocular pharmacotherapy

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7105 (2006.01) A61K 47/48 (2006.01) A61P 27/02 (2006.01)

Patent

CA 2513004

The invention provides nucleic acid therapeutic compositions capable of binding to cytokines, growth factors and cell surface proteins, individually or in combinations of two or more, and methods for delivering these nucleic acid therapeutics in the treatment of glaucoma and other proliferative diseases of the eye.

L'invention porte sur des compositions thérapeutiques d'acide nucléique capables de se lier à des cytokines, des facteurs de croissance et des protéines de surface cellulaire, individuellement ou par combinaison d'au moins deux, ainsi que sur des procédés d'administration de ces agents thérapeutiques d'acide nucléique dans le traitement du glaucome ou d'autres maladies proliférantes de l'oeil.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Aptamer therapeutics useful in ocular pharmacotherapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Aptamer therapeutics useful in ocular pharmacotherapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aptamer therapeutics useful in ocular pharmacotherapy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1500725

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.